Formulations:
- Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL
Indications:
- Other specified malignant neoplasms of bronchus or lung
- Other specified gliomas of brain
- Malignant neoplasms of nasopharynx
- Malignant neoplasms of breast
- Osteosarcoma of bone and articular cartilage of unspecified sites
- Other specified carcinomas of ovary
- Retinoblastoma
- Other specified malignant neoplasms of the ovary
- Germ cell tumour of testis
- Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx
- Malignant neoplasms of kidney, except renal pelvis
- Malignant neoplasms of cervix uteri
- Malignant neoplasms of hypopharynx
- Malignant neoplasms of oropharynx
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL
Indications:
- Other specified malignant neoplasms of bronchus or lung
- Other specified gliomas of brain
- Malignant neoplasms of nasopharynx
- Malignant neoplasms of breast
- Osteosarcoma of bone and articular cartilage of unspecified sites
- Other specified carcinomas of ovary
- Retinoblastoma
- Other specified malignant neoplasms of the ovary
- Germ cell tumour of testis
- Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx
- Malignant neoplasms of kidney, except renal pelvis
- Malignant neoplasms of cervix uteri
- Malignant neoplasms of hypopharynx
- Malignant neoplasms of oropharynx
Source: EML workbook import